8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2016 / Position statement
The Academy of Nutrition and Dietetics states that appropriately planned vegetarian, including vegan, diets are healthful, nutritionally adequate, and appropriate for all stages of the life cycle and athletes. Vegetarians and vegans have a reduced risk of conditions such as ischemic heart disease, type 2 diabetes, hypertension, certain cancers, and obesity. Diets low in saturated fat and high in vegetables, fruits, whole grains, legumes, soy, nuts, and seeds yield lower total and LDL cholesterol and improved glucose control. The position statement notes that vegans require reliable sources of vitamin B-12 from fortified foods or supplements.
Melina V, Craig W, Levin S J Acad Nutr Diet, 2016. PMID 27886704
2016 / Narrative review
This review examines how calorie restriction impacts the pathophysiology of type 2 diabetes. Negative calorie balance decreases liver fat within days, restoring normal hepatic glucose production control. Over 8 weeks, it allows intra-pancreatic fat levels and first-phase insulin secretion to normalize, supporting the Twin Cycle Hypothesis. The author notes type 2 diabetes can be understood as an excess fat state in the liver and pancreas, remaining reversible for at least 10 years in most individuals.
Taylor R Expert Rev Endocrinol Metab, 2016. PMID 30058916
2015 / Narrative review
This review takes a devil's advocate position to discuss subgroups of obese individuals who may not be adversely affected by their weight, or who may even benefit from higher adiposity. It examines situations where weight loss per se may not be the most appropriate recommendation. Specifically, it addresses adults with established cardiovascular disease, type 2 diabetes, weight cyclers, metabolically healthy obese adults, youth, older adults, and highly fit obese individuals.
Brown RE, Kuk JL Obes Rev, 2015. PMID 25410935
2015 / Narrative review
This review examines the relationship between the obesity epidemic and cancer incidence and outcomes. Obesity is associated with increased cancer incidence at a population level and may lead to poor cancer outcomes, though concurrent decreases in overall cancer mortality may reflect improvements in diagnosis and treatment. Biologically, active adipose tissue secretes estrogens, adipokines, and cytokines, and adipose reprogramming may lead to insulin resistance, impacting cancer progression locally, systemically, through pathways such as PI3K and JAK-STAT, or via the tumor microenvironment.
Shows an association, not proof of cause and effect.
Goodwin PJ, Stambolic V Annu Rev Med, 2015. PMID 25423596
2015 / Hypothesis / narrative review
Authors present the personal fat threshold (PFT) hypothesis to explain type 2 diabetes (T2DM) occurrence in normal-BMI individuals. Data from the UKPDS cohort of individuals diagnosed in the 1970s and 1980s showed a median BMI of 28 kg/m2, with one in three having a BMI under 25 kg/m2. The authors hypothesize that exceeding one's individual PFT triggers T2DM, and subsequent weight loss below this threshold permits return to normal glucose control regardless of whether the person is classified as obese by BMI.
Taylor R, Holman RR Clin Sci (Lond), 2015. PMID 25515001
2015 / Narrative review
This review evaluates the metabolic effects and mechanism of action of resveratrol, a polyphenol found in plant-based foods such as red wine. Resveratrol has been reported to have diverse healthful effects, including improving mitochondrial function and protecting against obesity, type-2 diabetes, cardiovascular dysfunction, and cancer cell growth. However, clinical trials investigating its metabolic effects have produced mixed results, leaving several controversies unresolved.
Bitterman JL, Chung JH Cell Mol Life Sci, 2015. PMID 25548801
2015 / Clinical practice guideline with systematic reviews
An Endocrine Society-appointed Task Force developed evidence-based clinical practice guidelines for the pharmacological management of obesity using the GRADE system and two systematic reviews. The guidelines concluded that medications approved for chronic weight management serve as useful adjuncts to lifestyle changes for patients who have been unsuccessful with diet and exercise alone. Furthermore, because many drugs prescribed for conditions such as diabetes and depression impact weight, prescribing medications with favorable weight profiles can aid obesity prevention and management.
Apovian CM, Aronne LJ, Bessesen DH, et al. J Clin Endocrinol Metab, 2015. PMID 25590212
2015 / Narrative review
Pre-clinical findings indicate that resveratrol may protect against various medical conditions and age-related complications. However, there is no consistent evidence of increased protection against metabolic disorders and other ailments when comparing animal and human studies. The review notes that most human studies examining resveratrol administration and patient outcomes have been limited by sample sizes. It evaluates advances in timing, dosage, formulation, bioavailability, toxicity, and drug interactions, as well as disease actions in cancer, diabetes, neurodegeneration, and cardiovascular disease.
Novelle MG, Wahl D, Diéguez C, et al. Ageing Res Rev, 2015. PMID 25625901
2015 / Narrative review
This review examines how modern electric lighting creates inadequate daytime light indoors and excessive light at night, disrupting human circadian rhythmicity. This disruption alters sleep/wake cycles, core body temperature, hormone regulation, and gene expression patterns. Epidemiological and mechanistic evidence suggests light-induced circadian disruption may contribute to modern conditions such as breast and prostate cancers, obesity, diabetes, and depression, with potential pathways involving melatonin suppression, circadian gene expression, and metabolism influenced in part by heme iron intake and distribution.
Shows an association, not proof of cause and effect.
Stevens RG, Zhu Y Philos Trans R Soc Lond B Biol Sci, 2015. PMID 25780233
2015 / Narrative review
This review evaluates the safety and efficacy of Moringa oleifera in human and animal studies. Five published human studies using powdered whole leaf preparations demonstrated anti-hyperglycemic (antidiabetic) and anti-dyslipidemic activities, with no adverse effects reported. Animal research also demonstrated tissue protective, antioxidant, and antihypertensive effects, among others. The authors note that product standardization remains an issue and additional human studies with standardized extracts are desirable.
Stohs SJ, Hartman MJ Phytother Res, 2015. PMID 25808883
2015 / Commentary / narrative review
Non-caloric artificial sweeteners (NAS) are widely consumed to combat weight gain and diabetes, but their role in promoting metabolic derangements remains controversial. The authors recently demonstrated that NAS consumption can induce glucose intolerance in mice and distinct human subsets through functional alterations of the gut microbiome. This commentary reviews these findings alongside other works and outlines the challenges in understanding how NAS impacts human health.
Suez J, Korem T, Zilberman-Schapira G, et al. Gut Microbes, 2015. PMID 25831243
2015 / Review
This review evaluates clinical evidence on dietary advanced glycation end products (AGEs) in chronic diseases, particularly chronic kidney disease (CKD). Clinical trials over the past decade show that an AGE-restricted diet reduces systemic AGE levels along with markers of oxidative stress and inflammation. These effects have been observed in CKD patients before and after starting dialysis, with or without coexisting diabetes. Reducing dietary AGEs through simple changes in culinary techniques is described as a feasible, safe, and easily applicable intervention.
Uribarri J, He JC Nephron, 2015. PMID 25871778
2015 / Narrative review
Since the 1980s, obesity prevalence has nearly doubled globally, with treatments including lifestyle modification, medications, and surgery. This review discusses the mechanisms and cardiometabolic implications of newly approved next-generation weight management medications. These medications demonstrate efficacy in initial weight management and long-term maintenance, while showing varying effects on diabetes and cardiovascular risks.
Wharton S, Serodio KJ Curr Cardiol Rep, 2015. PMID 25894803
2015 / Historical review and narrative summary
An early 1980s analysis of the metabolic profiles of 930 men and women showed that an abdominal distribution of fat for a given BMI is associated with increased insulin resistance and risk of type 2 diabetes and cardiovascular disease. This correlation has since been validated across multiple studies, establishing waist circumference as a diagnostic criterion for metabolic syndrome. Visceral fat represents one of several ectopic fat depots utilized when subcutaneous adipose tissue cannot accommodate excess fat due to limited expandability.
Shows an association, not proof of cause and effect.
Smith U J Clin Invest, 2015. PMID 25932676
2015 / Narrative review
Approximately 90% of the US population fails to consume recommended fiber levels (25 g/d for women, 38 g/d for men), averaging only 15 g/d. Fiber supplements cannot be assumed to provide the same health benefits as intact dietary fiber from whole foods, as only a minority possess the physical characteristics that drive clinical efficacy. This review focuses on four primary fiber characteristics driving efficacy—solubility, degree/rate of fermentation, viscosity, and gel formation—as well as gel-dependent small-bowel mechanisms that influence outcomes such as cholesterol lowering and glycemic control.
McRorie JW Nutr Today, 2015. PMID 25972618
2015 / Narrative review
This review summarizes scientific evidence regarding potential mechanisms by which non-nutritive sweeteners (NNSs) might promote metabolic dysregulation. Epidemiological studies link NNS consumption, primarily from diet sodas, with increased risk for obesity, metabolic syndrome, and type 2 diabetes. Proposed mechanisms include interference with learned responses controlling glucose and energy homeostasis, disruption of gut microbiota inducing glucose intolerance, and interaction with sweet-taste receptors in the digestive tract. Laboratory findings also demonstrate an association between individual taste sensitivity to sucralose and acute metabolic responses to an oral glucose load.
Shows an association, not proof of cause and effect.
Pepino MY Physiol Behav, 2015. PMID 26095119
2015 / Systematic review
A systematic review identified three randomized controlled clinical trials evaluating therapeutic fasting regimens on surrogate outcomes in humans, finding improvements in weight and other risk-related outcomes. In addition, two observational studies were identified in which fasting was associated with a lower prevalence of coronary artery disease or diabetes diagnosis. No randomized controlled trials of fasting for clinical outcomes were identified, and researchers concluded that substantial further human research is needed.
Horne BD, Muhlestein JB, Anderson JL Am J Clin Nutr, 2015. PMID 26135345
2015 / Narrative review
This review discusses the physiological functions and potential therapeutic role of the zero-calorie functional sweetener D-allulose in managing obesity and type 2 diabetes mellitus. Human trials cited in the review demonstrated that D-allulose attenuates postprandial glucose levels in healthy subjects and in individuals with borderline diabetes. In cell culture and animal models, D-allulose demonstrated anti-hyperlipidemic, anti-hyperglycemic, and anti-inflammatory properties, with rapid elimination in rat urine within 24 hours.
Hossain A, Yamaguchi F, Matsuo T, et al. Pharmacol Ther, 2015. PMID 26297965
2015 / Narrative review of observational studies
This review focused on human observational studies examining maternal plant-based and plant-rich dietary patterns during gestation. Maternal intake of adequate amounts of vegetables, fruits, and selected antioxidants was associated with a reduced risk of pediatric wheeze, diabetes, neural tube defects, orofacial clefts, and some pediatric tumors. Conversely, a low intake of plant foods could increase risks of preeclampsia, pregravid obesity, and genotoxicant susceptibility. The authors also noted that improperly balanced plant-based diets during gestation could risk deficiencies in key nutrients including n-3 fatty acids, vitamin B-12, iron, zinc, and iodine.
Shows an association, not proof of cause and effect.
Pistollato F, Sumalla Cano S, Elio I, et al. Adv Nutr, 2015. PMID 26374180
2015 / Narrative review
This review summarizes evidence on the functional role of palm oil and its primary saturated fatty acid, palmitic acid, in human health and nutrition. It addresses controversial studies linking high palmitic acid content to potential adverse effects. The article specifically evaluates their involvement in obesity, type 2 diabetes mellitus, cardiovascular diseases, and cancer, alongside the atherogenic potential and stereospecific position of palmitic acid in triacylglycerols.
Mancini A, Imperlini E, Nigro E, et al. Molecules, 2015. PMID 26393565
2015 / Narrative review
This review examines literature regarding the adverse effects of primary sleep deficiency and deprivation on the cardiovascular system. Decreased sleep quantity and quality have been associated with cardiovascular disease risk factors, including hypertension, obesity, diabetes, and dyslipidemia. The authors cite endothelial dysfunction as a common underlying mechanism connecting sleep deficiency to cardiovascular disease.
Shows an association, not proof of cause and effect.
Kohansieh M, Makaryus AN Int J Hypertens, 2015. PMID 26495139
2015 / Narrative review
This narrative review evaluates cardiovascular diseases through an evolutionary biology perspective. Ancestral exposure to infections and starvation selected for proinflammatory genes, fat accumulation via a thrifty genotype, and insulin resistance to sustain gluconeogenesis. Today, obesity promotes a proinflammatory state through adipokine secretion, contributing to cardiometabolic disease, atherosclerosis, and diabetes. The abstract suggests that if an ancestral lifestyle of increased exercise and calorie restriction could be recovered, obesity, chronic low-grade inflammation, atherosclerosis, and diabetes could theoretically be reduced.
Rubio-Ruiz ME, Peredo-Escárcega AE, Cano-Martínez A, et al. Int J Evol Biol, 2015. PMID 26693381
2015 / Narrative review
This narrative review examines the relationship between obesity, insulin resistance, and cancer. Globally, overweight and obese individuals increased from just over 500 million in 2008 to 1.9 billion in 2014, with at least 2.8 million related deaths occurring each year. The authors note that expansion of adipose tissue leads to insulin resistance and hyperinsulinemia, which provide a clear link between obesity and the etiology of type 2 diabetes and cancer.
Shows an association, not proof of cause and effect.
Poloz Y, Stambolic V Cell Death Dis, 2015. PMID 26720346
2014 / Review
A review examined the effects of vegetarian diets on non-communicable diseases. Mortality from all-cause, ischemic heart disease, and circulatory and cerebrovascular diseases was significantly lower in vegetarians compared with omnivorous populations. The incidence of cancer and type 2 diabetes was also significantly lower in vegetarians. However, vegetarians presented increased risk factors including higher plasma homocysteine, mean platelet volume, and platelet aggregability, which were associated with low intakes of vitamin B12 and n-3 polyunsaturated fatty acids.
Shows an association, not proof of cause and effect.
NANO counterpoint →
Li D J Sci Food Agric, 2014. PMID 23965907